Black Rock Inc. Orchard Therapeutics PLC Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.45 - $0.69 $9,695 - $14,866	-21,546 Reduced 2.94%	712,001 $356,000
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.78 $6,906 - $12,825	-16,443 Reduced 2.19%	733,547 $429,000
Q1 2022 May 12, 2022	BUY	$0.7 - $1.51 $87,134 - $187,961	124,478 Added 19.9%	749,990 $534,000
Q4 2021 Feb 10, 2022	SELL	$1.16 - $2.23 $31,692 - $60,925	-27,321 Reduced 4.18%	625,512 $826,000
Q3 2021 Nov 09, 2021	SELL	$2.24 - $4.29 $51,257 - $98,168	-22,883 Reduced 3.39%	652,833 $1.5 Million
Q2 2021 Aug 11, 2021	BUY	$4.39 - $7.23 $2.97 Million - $4.89 Million	675,716 New	675,716 $2.97 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.